Skip to main content

Peer Review reports

From: Severe colitis after PD-1 blockade with nivolumab in advanced melanoma patients: potential role of Th1-dominant immune response in immune-related adverse events: two case reports

Original Submission
9 Nov 2018 Submitted Original manuscript
17 Jul 2019 Author responded Author comments - Koji Yoshino
7 Jun 2019 Reviewed Reviewer Report - Alejandra Moreno LeBlanc
18 Jun 2019 Reviewed Reviewer Report - Reviewer 2
Resubmission - Version 2
17 Jul 2019 Submitted Manuscript version 2
24 Aug 2019 Author responded Author comments - Koji Yoshino
29 Jul 2019 Reviewed Reviewer Report - Alejandra Moreno LeBlanc
6 Aug 2019 Reviewed Reviewer Report - Reviewer 2
Resubmission - Version 3
24 Aug 2019 Submitted Manuscript version 3
31 Aug 2019 Author responded Author comments - Koji Yoshino
Resubmission - Version 4
31 Aug 2019 Submitted Manuscript version 4
Publishing
5 Sep 2019 Editorially accepted
29 Oct 2019 Article published 10.1186/s12885-019-6138-7

You can find further information about peer review here.

Back to article page
\